LeonardSMarksMD

PubMed

• 103 citations
  Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia
  Claus G. Roehrborn, Leonard S. Marks, Tom Fenter, Sheldon Freedman, John P. Tuttle
  Urology. 2004-04-01
• 23 citations
  Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection.
  David C. Johnson, Jason J. Yang, Lorna Kwan, Danielle Barsa, Sohrab Afshari Mirak
  Cancer. 2019-09-01
• 305 citations
  Value of Targeted Prostate Biopsy Using Magnetic Resonance–Ultrasound Fusion in Men with Prior Negative Biopsy and Elevated Prostate-specific Antigen
  Geoffrey A. Sonn, Edward F. Chang, Shyam Natarajan, Daniel Margolis, Malu Macairan
  European Urology. 2014-04-01

Journal Articles

• Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial  
  Warren Grundfest, Jiaoti Huang, Leonard S Marks, The Journal of Urology
• MRI Before Prostate Biopsy  
  Albertsen PC,Marks, LS, J Urol, 12/1/2013
• Target detection: Magnetic resonance imaging-ultrasound fusion-guided prostate biopsy  
  Sonn GA, Margolis DJ, Marks LS, Urol Oncol, 11/1/2013
• Prospective, Multi-Center Evaluation of the Beckman Coulter Prostate Health Index Using WHO Calibration  
  Loeb S, Sokoll LJ, Broyles DL, Bangma CH, van Schaik RH, Klee GG, Wei JT, Sanda MG, Partin AW, Slawin KM, Marks LS, Mizrahi IA, Shin SS, Cruz AB, Chan DW, Roberts WL, ..., J Urol, 5/1/2013
• Value of Targeted Prostate Biopsy Using Magnetic Resonance-Ultrasound Fusion in Men with Prior Negative Biopsy and Elevated Prostate-specific Antigen  
  Sonn GA, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS, Eur Urol, 3/1/2013
• BPH Registry Steering Committee Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observatio...  
  Wei JT, Miner MM, Steers WD, Rosen RC, Seftel AD, Pasta DJ, Carman WJ, Roehrborn CG, J Urol, 9/1/2011
• Effect of silodosin on specific urinary symptoms associated with benign prostatic hyperplasia: analysis of international prostate symptom scores in 2 phase III clinica...  
  Gittelman MC, Marks LS, Hill LA, Volinn W, Hoel G, Open J Urol, 12/1/2010
• Words of Wisdom Re: Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 prospective Studies  
  Marks LS, Eur Urol, 3/1/2009
• Prostate Cancer Gene 3 (PCA3): development and Internal Validation of a Novel Biopsy Nomogram  
  Chun FK, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, huland H, Abbou CC, Stillebroer AB, van Gils MP, Schalken JA, Fradet Y, Marks LS, Ellis W, P..., Eur Urol, 1/1/2009
• Prostate Tissue Androgens: History and Current Clinical Relevance  
  Marks LS, Mostaghel EA, Nelson PS, Urology, 8/1/2008
• The Effect of Dutasteride on the Peripheral and Transition Zones of the Prostate and the Value of the Transition Zone Index in Predicting Treatment Response  
  Marks LS, Roehrborn CG, Wolford E, Wilson TH, Urology, 4/1/2007
• Interpretation of Serum Prostate Specific Antigen Levels in Men Receiving 5 alpha-Reductase Inhibitors: A Review and Clinical Recommendations  
  Marks LS, , Andriole GL, Fitzpatrick JM, Schulman CC, Roehrborn CG, J Urol, 9/1/2006
• Relationship among Serum Testosterone, Sexual Function, and Response to Treatment in Men Receiving Dutsteride for Benign Prostatic Hyperplasia  
  Marberger M, Roehrborn CG, Marks LS, Wilson T, Rittmaster RS, J Clin Endocrinol Metab, 4/1/2006
• Use of 5 alpha Reductase Inhibitors in the Prevention of BPH Disease  
  Marks LS, Curr. Urol. Reports, 1/1/2006
• Enlarged Prostate: A Landmark National Survery of its Prevalence and Impact on US Men and their Partners  
  Roehrborn CG, Marks LS, Harkaway R, Prostate Cancer Prostatic Dis, 1/1/2006
• Testosterone Supplementation and the Prostate: Review of the Safety Issue  
  Marks LS, Nelson PS, Issue. Curr. Opin. Endocrinol. Diabetes, Obesity, 1/1/2006
• Prevention of BPH Disease  
  Marks LS, Roehrborn CG, Andriole GL, J Urol, 1/1/2006
• Efficacy and Tolerability of Darifenacin, a Muscarinic M3 selective Receptor Antagonist (M3 SRA), Compared with Oxybutinin in Treatment of Patients with Overactive Bla...  
  Zinner N, Tuttle J, Marks LS, World J Urol, 1/1/2005
• Untreated Syphilis in Negro Male: A Closure Comes to the Tuskegee Study  
  Baker S, Brawley O, Marks LS, Urology, 1/1/2005
• Stroma-epithelial Measurements of Prostate Cancer in Native Japanese and Japanese-American Men  
  Veltri RW, Park J, Miller MC, Marks LS, Kojima M, van Rootselaar C, Khan MA, Partin AW, Prostate Cancer Prostatic Dis, 1/1/2004
• Effect of Dutasteride on the Detection of Prostate cancer in Men with Benign Prostatic Hyperplasia (editorial comment), GL Andriole, et al  
  Marks LS, Urology, 1/1/2004
• 5 Alpha Reductase: History and Clinical Importance  
  Marks LS, Rev Urol, 1/1/2004
• Prostate Cancer in Native Japanese and Japanese-American Men: Effects of Dietary Differences on Prostate Tissues  
  Marks LS, Kojima M, Demarzo AM, et al, Urology, 1/1/2004
• Benign prostate-specific antigen (BPSA) , a subform of free prostate specific antigen in serum, is elevated in men with benign prostate disease  
  Harry J. Linton, Leonard S. Marks, Lisa S. Millar, Christine L. Knott, Harry G. Rittenhouse, Stephen D. Mikolajczyk, Clin Chem, 2/1/2003
• PSA as a biomarker for benign prostatic hyperplasia disease progression  
  Partin AW, Roehrborn CG, Lieber MM, and Marks LS, Advanced Studies in Medicine of Johns Hopkins University, 1/1/2003
• Join now to see all

Books/Book Chapters

• Management of Prostate Cancer 
  Chapter: Beyond PSA: Promising New Markers for Prostate Cancer 
  Page 51 - 77Marks, L.SEditors: Klein, E.A. and Jones A.S..Springer, New York2012
• Current Urologic Therapy 
  Chapter: Renovascular Hypertension 
  Page 156 - 160Marks LSEditors: Kaufman, J.J.W.B. Saunders Co., Philadelphia1980
• Surgery Annual ’79 
  Chapter: Renovascular Hypertension 
  Page 313 - 361Kaufman, J.J., Marks, L.S., and Maxwell, M.HEditors: Nyhus, L.M..Appleton-Century-Crofts, New York1979
• Urology 
  Chapter: Renovascular Hypertension 
  Marks, L.S. and Kaufman, J.JEditors: Karafin, L. and Kendall, A.R.Harper and Row, Hagerstown, MD1978
• Join now to see all

Lectures

• Innovation: People, Places, and a Story About the Prostate 
  Dana Point, CA - 10/10/2013
• Targeted Prostate Biopsy via MRI-Ultrasound Fusion 
  Irvine, CA - 12/10/2012
• Prostate cancer 2010; Imaging to Manage Disease Risk 
  Chicago, IL - 11/1/2009
• Dihydrotestosterone (DHT), The Other Androgen. History and Clinical Relevance Today 
  Baltimore, MD - 2/2/2006
• “5 alpha reductase inhibition: history and clinical importance 
  Ottawa, Canada - 7/1/2005
• PCA3 Urine Test: Specificity and Improved Prostate Cell Recovery 
  Buellton, CA - 1/1/2005
• The race against time: Issues surrounding andropause 
  Los Angeles, CA - 6/1/2004
• BPH and Alpha-blockers, 2004: Alfuzosin, a new treatment 
  San Francisco, CA - 4/1/2004
• Recent advances in PSA testing 
  Orlando, FL, 2001; Chicago, IL, 2002 - 1/1/2002
• Saw Palmetto: Myth and Science 
  Dallas, TX - 3/1/2001
• Effect of Finasteride and Saw Palmetto Extracts in Men with Symptomatic Benign Prostatic Hyperplasia 
  Mexico City, Mexico - 1/1/1999
• Join now to see all